Here, in accordance with the GEPIA online database and clinical sample analysis, it was found that circFN1 in plasma samples of AML patients was signally up‐regulated in comparison with healthy controls, indicating that circ‐PTK2 may be an oncogene in AML. Here, PTK2 is linked to acute myeloid leukemia.